Kadmon Holdings Inc (NASDAQ:KDMN) major shareholder Goldentree Asset Management Lp sold 302,950 shares of the stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $2.73, for a total value of $827,053.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Goldentree Asset Management Lp also recently made the following trade(s):

  • On Monday, July 31st, Goldentree Asset Management Lp sold 349,661 shares of Kadmon Holdings stock. The shares were sold at an average price of $2.60, for a total value of $909,118.60.
  • On Tuesday, July 11th, Goldentree Asset Management Lp sold 34,462 shares of Kadmon Holdings stock. The shares were sold at an average price of $3.69, for a total value of $127,164.78.
  • On Thursday, June 29th, Goldentree Asset Management Lp sold 64,375 shares of Kadmon Holdings stock. The shares were sold at an average price of $4.04, for a total value of $260,075.00.
  • On Tuesday, June 27th, Goldentree Asset Management Lp sold 108,827 shares of Kadmon Holdings stock. The shares were sold at an average price of $3.69, for a total value of $401,571.63.
  • On Monday, June 26th, Goldentree Asset Management Lp sold 515,643 shares of Kadmon Holdings stock. The shares were sold at an average price of $3.51, for a total value of $1,809,906.93.
  • On Thursday, June 22nd, Goldentree Asset Management Lp sold 767,363 shares of Kadmon Holdings stock. The shares were sold at an average price of $3.50, for a total value of $2,685,770.50.

Kadmon Holdings Inc (NASDAQ KDMN) traded up 7.87% on Thursday, hitting $2.74. The stock had a trading volume of 159,270 shares. The company has a 50 day moving average price of $2.47 and a 200-day moving average price of $2.95. The company’s market cap is $142.06 million. Kadmon Holdings Inc has a 52-week low of $2.05 and a 52-week high of $9.15.

Kadmon Holdings (NASDAQ:KDMN) last issued its earnings results on Thursday, August 3rd. The company reported ($0.44) EPS for the quarter, topping analysts’ consensus estimates of ($0.49) by $0.05. The company had revenue of $3 million during the quarter, compared to analysts’ expectations of $3.46 million. During the same quarter in the previous year, the company earned ($4.40) EPS. The firm’s quarterly revenue was down 53.1% compared to the same quarter last year. On average, equities research analysts predict that Kadmon Holdings Inc will post ($1.58) earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Insider Selling: Kadmon Holdings Inc (KDMN) Major Shareholder Sells 302,950 Shares of Stock” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/07/insider-selling-kadmon-holdings-inc-kdmn-major-shareholder-sells-302950-shares-of-stock.html.

Institutional investors and hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. boosted its stake in shares of Kadmon Holdings by 11,654.8% in the first quarter. JPMorgan Chase & Co. now owns 228,866 shares of the company’s stock worth $829,000 after buying an additional 226,919 shares during the last quarter. Perceptive Advisors LLC boosted its stake in shares of Kadmon Holdings by 134.7% in the first quarter. Perceptive Advisors LLC now owns 5,185,847 shares of the company’s stock worth $18,772,000 after buying an additional 2,976,190 shares during the last quarter. Nationwide Fund Advisors purchased a new stake in shares of Kadmon Holdings in the first quarter worth about $192,000. AE Wealth Management LLC purchased a new stake in shares of Kadmon Holdings in the first quarter worth about $391,000. Finally, Wells Fargo & Company MN boosted its stake in shares of Kadmon Holdings by 84.8% in the first quarter. Wells Fargo & Company MN now owns 51,291 shares of the company’s stock worth $186,000 after buying an additional 23,541 shares during the last quarter.

A number of research analysts have weighed in on KDMN shares. Zacks Investment Research downgraded Kadmon Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, May 23rd. HC Wainwright reissued a “buy” rating and issued a $25.00 target price on shares of Kadmon Holdings in a report on Monday, June 26th. Piper Jaffray Companies reissued a “buy” rating and issued a $7.00 target price on shares of Kadmon Holdings in a report on Friday, July 14th. Finally, ValuEngine downgraded Kadmon Holdings from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the stock. Kadmon Holdings currently has an average rating of “Hold” and an average price target of $8.92.

Kadmon Holdings Company Profile

Kadmon Holdings, Inc is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases.

Insider Buying and Selling by Quarter for Kadmon Holdings (NASDAQ:KDMN)

Receive News & Ratings for Kadmon Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.